AUPH
Aurinia Pharmaceuticals Inc
15.80$
-0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 3.2% | 3.3% | 3.2% | 2,160.2% | 37,265.5% | 28,035.5% | 29,623.3% | 36,220.7% | 2,973.9% | 37,375.9% | 35,436.7% | 38,455.2% | 7,735.2% | 45,834.5% | 46,116.7% | 38,193.1% | 16,551.7% | 41.2% | 5.3% | 4.7% | 1.7% | 2.1% | 1.2% | 5.7% | 4.4% | 4.8% | 1.2% | 3.8% | 12.4% | 12.0% | 15.4% | 15.6% | 8.9% | 9.3% | 13.7% | 10.2% | 11.6% | 11.0% | 8.4% | 7.9% | 9.6% | |
| 96.8% | 96.7% | 96.8% | -2,060.2% | -37,165.5% | -27,935.5% | -29,523.3% | -36,120.7% | -2,873.9% | -37,275.9% | -35,336.7% | -38,355.2% | -7,635.2% | -45,734.5% | 100.0% | 100.0% | 100.0% | 100.0% | 94.7% | 95.3% | 98.3% | 97.9% | 98.8% | 94.3% | 95.6% | 95.2% | 98.8% | 96.2% | 87.6% | 88.0% | 84.6% | 84.4% | 91.1% | 90.7% | 86.3% | 89.8% | 88.4% | 89.0% | 91.6% | 92.1% | 90.4% | |
| 10,780.6% | 18,206.7% | 23,629.0% | 2,160.2% | 37,265.5% | 28,035.5% | 29,623.3% | 36,220.7% | 2,973.9% | 37,375.9% | 35,436.7% | 38,455.2% | 7,735.2% | 45,834.5% | 46,116.7% | 38,193.1% | 42,217.2% | 26.3% | 1,075.8% | 152.4% | 136.8% | 47.6% | 58.4% | 40.9% | 19.7% | 34.7% | 38.2% | 30.5% | 25.0% | 22.7% | 11.0% | 7.1% | 4.5% | 13.5% | 9.2% | 10.6% | 11.5% | 14.1% | 9.6% | 15.7% | 12.8% | |
| 5,535.5% | 7,423.3% | 11,054.8% | 881.8% | 9,137.9% | 10,058.1% | 12,636.7% | 11,937.9% | 779.5% | 12,062.1% | 13,003.3% | 17,055.2% | 2,635.2% | 24,986.2% | 36,870.0% | 53,272.4% | 105,869.0% | 80.1% | 4,355.0% | 669.5% | 304.4% | 189.0% | 209.0% | 182.8% | 93.5% | 167.0% | 145.7% | 105.2% | 87.6% | 111.0% | 88.3% | 71.2% | 55.9% | 52.1% | 31.0% | 36.0% | 34.8% | 36.9% | 27.9% | 28.2% | 31.9% | |
| 17,483.9% | 26,846.7% | 35,854.8% | 3,154.4% | 47,651.7% | 39,258.1% | 43,590.0% | 49,548.3% | 3,862.1% | 50,662.1% | 49,716.7% | 56,837.9% | 10,539.6% | -45,734.5% | 90,300.0% | 92,731.0% | 146,013.8% | 116.1% | 5,624.6% | 807.3% | 441.6% | 237.7% | 274.0% | 222.0% | 112.6% | 194.0% | 184.8% | 135.2% | 117.4% | 133.7% | 105.9% | 87.1% | 73.8% | 93.5% | 51.3% | 61.2% | 47.9% | 45.9% | 38.3% | 36.4% | 42.0% | |
| -17,387.1% | -26,750.0% | -35,758.1% | -3,054.4% | -47,551.7% | -39,158.1% | -43,490.0% | -49,448.3% | -3,762.1% | -50,562.1% | -49,616.7% | -56,737.9% | -10,439.6% | -72,069.0% | -90,200.0% | -92,631.0% | -145,913.8% | -16.1% | -5,529.9% | -712.0% | -343.3% | -139.7% | -175.2% | -127.7% | -17.0% | -98.8% | -86.0% | -39.0% | -29.8% | -45.7% | -21.3% | -2.6% | 17.3% | -2.8% | 35.0% | 28.7% | 40.5% | 43.1% | 53.3% | 55.7% | 48.4% | |
| 22.6% | 23.3% | 245.2% | 127.4% | 1,375.9% | 616.1% | 800.0% | 2,179.3% | 184.3% | 2,313.8% | 36.7% | 34.5% | 3.9% | 31.0% | 83.3% | 269.0% | 348.3% | 0.7% | 18.8% | 2.1% | 0.7% | 0.5% | 1.2% | 1.7% | 2.6% | 10.2% | 11.1% | 0.2% | 2.6% | 2.9% | 2.6% | 2.1% | 1.8% | 1.9% | 1.7% | 1.6% | 1.5% | 8.4% | 1.3% | 1.1% | 3.1% | |
| -23,932.3% | -27,776.7% | -167,551.6% | -729.2% | -45,241.4% | -10,748.4% | -51,593.3% | -54,162.1% | -4,891.2% | -50,069.0% | -41,383.3% | -54,775.9% | -8,266.1% | -263,413.8% | -87,233.3% | -91,524.1% | -145,327.6% | -15.8% | -5,511.1% | -709.8% | -342.6% | -139.3% | -174.0% | -125.9% | -14.4% | -88.6% | -74.9% | -29.2% | -24.1% | -58.6% | -19.9% | 2.6% | 21.8% | 2.0% | 39.0% | 31.6% | 43.5% | 46.3% | 56.5% | 58.6% | 51.5% | |
| 6,545.2% | 1,026.7% | 131,793.5% | -2,325.2% | -2,310.3% | -29,045.2% | 8,103.3% | 4,713.8% | 1,129.1% | 251.7% | 43.3% | 55.2% | 10.9% | 310.3% | -793.3% | 6.9% | -51.7% | 0.3% | 0.9% | 0.3% | 0.1% | 3.1% | 0.0% | 0.0% | 1.7% | 3.0% | 1.3% | -1.5% | 0.5% | 1.0% | 1.5% | 1.3% | 0.7% | -0.4% | 1.6% | 0.9% | 0.6% | -227.1% | 12.3% | 13.7% | -49.4% | |
| -23,932.3% | -27,776.7% | -167,551.6% | -729.2% | -45,241.4% | -10,748.4% | -51,593.3% | -54,162.1% | -4,891.2% | -50,320.7% | -41,426.7% | -54,831.0% | -8,277.0% | -263,724.1% | -86,440.0% | -91,531.0% | -145,275.9% | -16.1% | -5,511.9% | -710.1% | -342.6% | -142.4% | -174.0% | -126.0% | -16.1% | -91.6% | -76.2% | -27.7% | -24.7% | -59.6% | -21.4% | 1.3% | 21.2% | 2.4% | 37.4% | 30.7% | 42.9% | 273.4% | 44.2% | 45.0% | 100.8% | |
| -16,219.4% | -25,533.3% | -32,912.9% | -2,941.9% | -46,303.4% | -39,671.0% | -50,263.3% | -52,772.4% | -4,782.4% | -49,337.9% | -40,070.0% | -53,413.8% | -8,093.0% | -262,034.5% | -82,820.0% | -91,531.0% | -144,182.8% | -19.4% | -5,484.4% | -697.0% | -337.4% | -136.3% | -170.1% | -122.4% | -13.0% | -87.8% | -72.8% | -27.4% | -11.5% | -34.7% | -7.7% | 13.1% | 30.9% | 12.0% | 48.5% | 40.2% | 50.1% | 61.0% | 64.0% | 65.6% | 60.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.